Iceutica Is A Privately Held Pharmaceutical Research And Development Company Located In King Of Prussiapa Iceutica Applies Our Proprietary Solumatrixa C Fine Particle Technology To Both Approved And Development Stage Drug Compoundscreating New Branded Medicines Independently And In Collaboration With Selected Pharmaceutical Partnersthe Resulting Products Provide Meaningful Clinical Benefits For Patients And Have Clearly Defined Pathways To Regulatory And Commercial Successthere Are Currently Four Fda Approved And Marketed Prescription Drugs That Use Solumatrix Fine Particle Technologypain Drugs Zorvolexa Ctivorbexa Cand Vivlodexa C And Prostate Cancer Drug Yonsaa In Additioniceutica And Our Partners Have Several Pipeline Products In Various Stages Of Development
